This systematic pan-cancer analysis suggested that NUP155 was differentially expressed between non-cancerous and cancer tissues and that NUP155 dysregulation is associated with tumor staging and can be used to predict the prognosis. The gene discussed is NUP155; the disease is neoplasm.